Indraprastha Apollo Hospitals Q3 FY26 Shines: ₹372 Cr Revenue, ₹41 Cr PAT Signals Healthcare Resilience

Q3 Financial Review
Indraprastha Medical Corporation Ltd unveiled strong December quarter results on February 3, 2026, reflecting robust healthcare demand at its 717-bed flagship Delhi facility. Revenue from operations reached ₹3.72 billion, up from prior trends, fueled by increased OPD/IPD footfall and premium services.
​
PAT stood at ₹410 million, underscoring operational efficiency with EBITDA margins holding firm ~20-22%. 9M FY26 trends positive, building on H1's ₹760 Cr total income.

Growth Catalysts
Expansion in oncology, cardiology, and international patient services; capacity utilization ~75%; debt-free balance sheet supports capex for bed additions.

Key Highlights

• Revenue Milestone: Dec-qtr rev from ops ₹3.72 bln (₹372 Cr).
• ​Profit Strength: PAT ₹410 mln (₹41 Cr); stable YoY amid volume surge.
• ​Operational Metrics: ARPOB up, occupancy steady; 9M revenue ~₹10.4 bln.
• ​Outlook: Capacity ramp-up, specialty focus to drive FY26 double-digit growth.

​
Sources: Moneycontrol, Marketscreener, MarketsMojo.